A PubMed Central-hosted review of peptide-based obesity treatments describes "nausea, vomiting and loss of appetite" as common effects of the GLP-1 drug class (pmc.ncbi.nlm.nih.gov)
Chutima Roomruangwong, Chulalongkorn University, Thailand Updates Copyright 2023 da Silva Schmidt, Trettim, Longoni, Grings, de Matos, de Avila Quevedo, Ardais, Nedel, Ghisleni, Leipnitz, Pinheiro and de Assis
The vial may look partially empty, but this is completely normal and doesnt indicate an incorrect amount
In animal and lab studies, BPC-157s gut health benefits include faster ulcer healing, protection against NSAID-induced stomach lining damage, and support for the intestinal barrier, potentially helping reduce inflammation in the digestive tract